Preliminary Analysis of the Antimicrobial and Anti-inflammatory Activity of Lobelia Species Medicinally Used by Native Americans

Advisor(s)

Dr. Jill Bennett-Toomey

Dr. Lisa Walden

Dr. Linda Young

Confirmation

1

Document Type

Poster

Location

McIntosh Activities Room

Start Date

19-4-2024 10:00 AM

End Date

19-4-2024 10:50 AM

Abstract

Historical use of Lobelia species suggests antimicrobial and anti-inflammatory activity. We screened the following constituents for antimicrobial activity: perilla ketone, δ-carene, myrcene, isophytol, allyl nonanoate, limonene, camphorquinone and lobelin hydrochloride. These constituents were applied at ~ 10 µg/6mm filter paper dot for Kirby-Bauer assay against Staphylococcus aureus, Streptococcus pneumoniae, Escherichia coli, Pseudomonas aeruginosa and Candida albicans. Zones of inhibition were observed against S. pneumoniae for perilla ketone (21 mm), allyl nonanoate (14.5 mm) and myrcene (8 mm). Synergy studies with these 3 constituents are on-going. Ethanolic extracts of Lobelia species cardinalis, inflata and siphilitica were applied at 100 µg plant material/dot for Kirby-Bauer assays against Streptococcus pyogenes, carbapenem-resistant Klebsiella pneumoniae, vancomycin-resistant Enterococcus faecalis and the previously screened microbes. S. pneumoniae again developed zones of inhibition: cardinalis (10.3 mm), inflata, (9.3 mm) and siphilitica (9.7 mm), showing moderate antibiotic efficacy with all species. Anti-inflammatory activity was examined by immunocytochemistry. Lobelia spp. extracts were used to treat mouse granulosa cells at 30 minutes and 1 hour following LPS-induced inflammation. Cardinalis showed minimal suppression of inflammation. Siphilitica was shown to suppress inflammation within the 30-minute treatment, followed by Inflata suppression within the 1 hour treatment.

Level of Access

Open Access

This document is currently not available here.

Open Access

Available to all.

Share

COinS
 
Apr 19th, 10:00 AM Apr 19th, 10:50 AM

Preliminary Analysis of the Antimicrobial and Anti-inflammatory Activity of Lobelia Species Medicinally Used by Native Americans

McIntosh Activities Room

Historical use of Lobelia species suggests antimicrobial and anti-inflammatory activity. We screened the following constituents for antimicrobial activity: perilla ketone, δ-carene, myrcene, isophytol, allyl nonanoate, limonene, camphorquinone and lobelin hydrochloride. These constituents were applied at ~ 10 µg/6mm filter paper dot for Kirby-Bauer assay against Staphylococcus aureus, Streptococcus pneumoniae, Escherichia coli, Pseudomonas aeruginosa and Candida albicans. Zones of inhibition were observed against S. pneumoniae for perilla ketone (21 mm), allyl nonanoate (14.5 mm) and myrcene (8 mm). Synergy studies with these 3 constituents are on-going. Ethanolic extracts of Lobelia species cardinalis, inflata and siphilitica were applied at 100 µg plant material/dot for Kirby-Bauer assays against Streptococcus pyogenes, carbapenem-resistant Klebsiella pneumoniae, vancomycin-resistant Enterococcus faecalis and the previously screened microbes. S. pneumoniae again developed zones of inhibition: cardinalis (10.3 mm), inflata, (9.3 mm) and siphilitica (9.7 mm), showing moderate antibiotic efficacy with all species. Anti-inflammatory activity was examined by immunocytochemistry. Lobelia spp. extracts were used to treat mouse granulosa cells at 30 minutes and 1 hour following LPS-induced inflammation. Cardinalis showed minimal suppression of inflammation. Siphilitica was shown to suppress inflammation within the 30-minute treatment, followed by Inflata suppression within the 1 hour treatment.